Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients episode artwork

EPISODE · Nov 26, 2015 · 1 MIN

Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

from GRACEcast · host cancerGRACE Meetings

Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.

Episode metadata supplied by the publisher feed · Published Nov 26, 2015

Embed this episode

NOW PLAYING

Clinical Trial Spotlight: Targeting Brain Mets in EGFR Lung Cancer Patients

0:00 1:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 1 minute long.

When was this GRACEcast episode published?

This episode was published on November 26, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!